Clinical effect of the principle of tonifying-kidney, invigorating-spleen, nourishing and activating-blood on patients with vascular dementia

Chinese Journal of Clinical Rehabilitation

Volumn 7, Issue 31, 2003, Pages 4251-4253

  Cai, Jing ^a   Du, Jian ^a   Huang, Jun Shan ^b   Lin, Qiu Cheng ^a  

^a FUJIAN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; CHRYSANTHEMUM EXTRACT; CRATAEGUS EXTRACT; DIHYDROERGOTOXINE MESILATE; ESTRADIOL; HERBACEOUS AGENT; HOMOCYSTEINE; KANGXIN; SALVIA MILTIORRHIZA EXTRACT; SEX HORMONE; TESTOSTERONE; UNCLASSIFIED DRUG;

ARTICLE; BIOCHEMISTRY; BLOOD; CHRYSANTHEMUM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRATAEGUS; DIAGNOSTIC PROCEDURE; DRUG CAPSULE; DRUG DOSE REGIMEN; DRUG EFFICACY; EPIMEDIUM; FEMALE; FRUIT; HERB; HUMAN; KIDNEY; MAJOR CLINICAL STUDY; MALE; MULTIINFARCT DEMENTIA; PATIENT SELECTION; PLANT ROOT; PLANT SEED; RANDOMIZED CONTROLLED TRIAL; RHIZOME; SALVIA MILTIORRHIZA; SEX DIFFERENCE; SPLEEN; STANDARD; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

EID: 2442428504     PISSN: 16715926     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Tian JZ, han MX, Tu JW, et al. Diagnosis, analysis and effect evaluation criterion of vascular dementia. Zhongguo Laonianxue Zazhi 2002; 22(5): 329-31
2. Zhang TQ, Gu AX, Zhu RH. Risk factors of vascular dementia and its prevention and cure. Xiandai Kangfu 2001; 5(5): 61-2
3. Che HL, Jia JP. Clinical study of 129 cases of senile dementia. Zhongfeng Yu Shenjing Jibing Zazhi 2002; 19(4): 213-5
4. Hu SJ. A important study on the unconventional risk factors of atherosclerosis. Zhejiang Daxue Xuebao (Yixueban) 2002; 31(5): 313-5
5. Zhu JH, Zhang L. Effects of homocysteine on the excretion and expression of blood smooth muscle cells in rats. Zhongguo Bingli Shengli Zazhi 2002; 18(9): 1126-8
6. Rotland PH, Friggi A, Barlatier A, et al. Hyperhomocysteinemia induced vascular damage in the minipig: Captopril-hydrochlorothiazide combination prevents elastic alterations. Circulation 1995; 91: 1161-74
7. Harpel PC, Zhang X, Borth W. Homocysteine and homostasis: Pathogenic mechanisms predisposing to thrombosis. J Nutr 1996; 126: 1285-9
8. Gao W, Jiang N, Zhu GY, et al. Investigation of the changes of homocysteine levels and its mechanism in plasm of patients with coronary heart disease. Zhonghua Yixue Zazhi 1998; 78(11): 821-3
9. Liu Qp, Liu GR, Li YC. Relationship of homocysteine to several types of cerebrovascluar diseases. Nao Yu Shenjing Jibing Zazhi 2002; 10(5): 319
10. Deng ZR, Yang GQ, Chen XY. Correlation of homocysteine to hypertension and coronary heart disease. Xi' an Jiaotong Daxue Xuebao (Yizueban) 2002; 23(5): 468-9,482
11. Koistinaho J, PyykonenI, Keinanen R, et al. Expression of beta-amyloid precursor protein mRNAs following transient focal ischaemia. Neuroreport 1996; 7(15-17): 2727-31
12. Birge SJ, Mortel KF. Estrogen and the treatment of Alzheimer's disease. Am J Med 1997; 103(3A): 46-50
13. Whitmer RA, Haan MN, Miller JW, et al. Hormone replacement therapy and cognitive performance: the role of homocysteine. J Gerontol A Biol Sci Med Sci 2003; 58(4): 324-30
14. Asthana S. Estrogen and cognition: the story so far. J Gerontol A Biol Sci Med Sci 2003; 58(4): 322-3